United Therapeutics (UTHR) is an Incredible Growth Stock: 3 Reasons WhyZacks Investment Research • 05/06/24
United Therapeutics Corporation (UTHR) Hits Fresh High: Is There Still Room to Run?Zacks Investment Research • 05/06/24
Compared to Estimates, United Therapeutics (UTHR) Q1 Earnings: A Look at Key MetricsZacks Investment Research • 05/01/24
CORRECTING and REPLACING PHOTO United Therapeutics Announces World's First Successful Xenothymokidney TransplantBusiness Wire • 04/26/24
United Therapeutics Announces World's First Successful Xenothymokidney TransplantBusiness Wire • 04/24/24
United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024Business Wire • 04/24/24
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International ConferenceBusiness Wire • 04/16/24
United Therapeutics Announces the First Comprehensive Review Publication on XenotransplantationBusiness Wire • 03/26/24
Why Is United Therapeutics (UTHR) Up 8.9% Since Last Earnings Report?Zacks Investment Research • 03/22/24
United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024Business Wire • 03/05/24
United Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care ConferenceBusiness Wire • 02/27/24
Wall Street Analysts Think United Therapeutics (UTHR) Could Surge 32.73%: Read This Before Placing a BetZacks Investment Research • 02/22/24